title: Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
abstract: Viral and synthetic single-stranded RNAs are the ligands for Toll-like receptor (TLR)7 and TLR8. However, single-stranded RNA is rapidly degraded by ubiquitous RNases, and the studies reported to date have used RNA with lipid carriers. To overcome nuclease susceptibility of RNA, we have synthesized several RNAs incorporating a range of chemical modifications. The present study describes one pool of RNA compounds, referred to as stabilized immune modulatory RNA (SIMRA) compounds, in which two RNA segments are attached through their 3' ends. SIMRA compounds showed greater stability in human serum compared with linear RNA and activated human TLR8, but not TLR7, in HEK293 cells without using lipid carriers. Interestingly, another set of SIMRA compounds containing 7-deazaguanosine substituted for natural guanosine activated human TLR7 and TLR8. Additionally, TLR7- and TLR8-activating compounds, but not the compounds that activated only TLR8, stimulated mouse immune cells in vitro and in vivo and produced dose-dependent T helper 1-type cytokines. Both types of compounds activated human peripheral blood mononuclear cells, but only TLR7- and TLR8-activating compounds activated plasmacytoid dendritic cells and produced high levels of IFN-alpha. In monkeys, s.c. administration of both types of SIMRA compounds induced transient changes in peripheral blood monocytes and neutrophils, and activated T lymphocytes, monocytes, and NK cells. Both types of compounds induced IFN-gamma-inducible protein 10, but only the 7-deazaguanosine-containing compound that activated both TLR7 and TLR8 induced IFN-alpha in monkeys. This is a comprehensive study of RNA-based compounds containing structures and synthetic stimulatory motifs in mouse, monkey, and human systems without using lipid carriers.
authors: Idera Pharmaceuticals, Inc., 167 Sidney Street, Cambridge, MA 02139, USA.
authors: Tao
authors: T
authors: Lan
authors: Ekambar R
authors: ER
authors: Kandimalla
authors: Dong
authors: D
authors: Yu
authors: Lakshmi
authors: L
authors: Bhagat
authors: Yukui
authors: Y
authors: Li
authors: Daqing
authors: D
authors: Wang
authors: Fugang
authors: F
authors: Zhu
authors: Jimmy X
authors: JX
authors: Tang
authors: Mallikarjuna R
authors: MR
authors: Putta
authors: YanPing
authors: Y
authors: Cong
authors: Anthony F
authors: AF
authors: Trombino
authors: Tim
authors: T
authors: Sullivan
authors: Sudhir
authors: S
authors: Agrawal
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology; D015195:Drug Design; D006801:Humans; D007155:Immunologic Factors / Q000235:genetics* / Q000494:pharmacology*; D008252:Macaca fascicularis; D051379:Mice; D012313:RNA / Q000235:genetics / Q000494:pharmacology*; D020871:RNA Stability / Q000187:drug effects / Q000235:genetics; D013154:Spleen / Q000187:drug effects / Q000378:metabolism; D051199:Toll-Like Receptor 7 / Q000819:agonists* / Q000235:genetics / Q000378:metabolism*; D051200:Toll-Like Receptor 8 / Q000819:agonists* / Q000235:genetics / Q000378:metabolism*
chemical_list: D016207:Cytokines; D007155:Immunologic Factors; C495348:TLR7 protein, human; C495349:TLR8 protein, human; D051199:Toll-Like Receptor 7; D051200:Toll-Like Receptor 8; D012313:RNA
references: Eur J Immunol. 2000 Jan;30(1):1-7
references: 10602021
references: Blood. 2007 Apr 1;109(7):2953-60
references: 17132722
references: J Pharmacol Exp Ther. 2001 Sep;298(3):1185-92
references: 11504819
references: Nature. 2001 Oct 18;413(6857):732-8
references: 11607032
references: Nat Immunol. 2002 Feb;3(2):196-200
references: 11812998
references: Annu Rev Immunol. 2002;20:197-216
references: 11861602
references: Nucleic Acids Res. 2002 Oct 15;30(20):4460-9
references: 12384593
references: Proc Natl Acad Sci U S A. 2003 May 27;100(11):6646-51
references: 12738885
references: Biochem Biophys Res Commun. 2003 Dec 26;312(4):1220-5
references: 14652004
references: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14303-8
references: 14610275
references: Ann N Y Acad Sci. 2003 Dec;1002:30-42
references: 14751820
references: Eur J Immunol. 2004 Feb;34(2):537-47
references: 14768059
references: Science. 2004 Mar 5;303(5663):1529-31
references: 14976261
references: Science. 2004 Mar 5;303(5663):1526-9
references: 14976262
references: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5598-603
references: 15034168
references: Nat Immunol. 2004 Oct;5(10):987-95
references: 15454922
references: Eur J Biochem. 1970 Apr;13(3):558-64
references: 5444162
references: J Virol. 1998 Apr;72(4):2752-9
references: 9525594
references: Nature. 2004 Nov 11;432(7014):173-8
references: 15538359
references: Eur J Immunol. 2005 Jan;35(1):236-42
references: 15593126
references: J Immunol. 2005 Jan 15;174(2):767-76
references: 15634897
references: Nat Med. 2005 Mar;11(3):263-70
references: 15723075
references: Proc Natl Acad Sci U S A. 2005 May 10;102(19):6925-30
references: 15860583
references: Adv Exp Med Biol. 2005;560:11-8
references: 15932016
references: Biochem Biophys Res Commun. 2006 Feb 17;340(3):807-14
references: 16380083
references: Eur J Immunol. 2006 Oct;36(10):2807-16
references: 17013976
references: Eur J Immunol. 2006 Dec;36(12):3256-67
references: 17111347
references: Nature. 2000 Dec 7;408(6813):740-5
references: 11130078